Baker & Eastlack Ventures
Baker & Eastlack Ventures
  • Home
  • About
  • Portfolio
  • Investment Focus
  • News
  • Contact

Kurin Receives Additional Patent Claims

November 17, 2020

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office of Additional Claims to its Innovative Blood Culture Collection Device.

Kurin, Inc. receives FDA 510k clearance for its push-button needle Kurin Reports Record Revenue

Related Posts

Uncategorized

Micron Medical Appoints Seasoned Healthcare Executive Mark Landy as Chief Executive Officer

Uncategorized

Zerigo Now Approved as a MultiPlan Participating Provider

Uncategorized

Spinal Singularity Hires New CEO

Baker & Eastlack Ventures

Contact Us

Email: bakerandeastlack@gmail.com

© Baker & Eastlack Ventures 2023